PROGRAMME 2024

Special Populations in Drug Development and Clinical Care:
Across the Entire Life Span from Paediatrics to Geriatrics

08:30                          

Opening of Registration Desk

09:00

Welcome by SGPM, President Martin Traber
Welcome by DGPharMed, President Peter Schüler
 Welcome by IFAPP President elect Eric Klaver 

INTRODUCTION

Chair: Antonio Amodeo, CTC, Zürich & Donal Martin McHugh, Pfizer

SESSION I: How to Deal with Vulnerable Populations

09:15-10:00 

Clinical Trials Involving Vulnerable Groups and Individuals: Ethical Considerations
Julian März, Institute of Biomedical Ethics and History of Medicine, University of Zurich

SESSION II: Paediatric Aspects

10:00-10:30               

Developmental Pharmacology and Pharmacometrics to Facilitate Neonatal and Paediatric Drug Development
Verena Gotta, Children’s Hospital (UKBB), Basel

10:30-11:00  Coffee Break

11:00-11:30               

Clinical Trials in Children
SwissPedNet, Matthias Baumgartner, Children’s Hospital (Kispi), Zurich

11:30-12:00

Swissmedic’s Regulatory and Clinical Considerations on paediatric investigation plans
Cornelia Bigler, Swissmedic, Berne and
Jeanette Bachir, Swissmedic, Berne

SESSION III:  Women Health, Pregnancy and Gender Effects

12:00-12:40 

Gender Pharmacology/Medicine
Carolin Lerchenmüller, Gender Medicine, University Hospital Zurich

12:40-14:00  Lunch Break

14:00-14:30

Familiy Planning: Case Study of Ocrevus during Pregnancy and Lactation
Noemi Pasquarelli, F. Hoffmann-La Roche, Basel

SESSION IV: Geriatrics

14:30-15:00               

Including Geriatric Population in Clinical Trials
Angélique Sadlon, University Psychiatric Clinics (UPK), Basel

15:00-15:30  Coffee Break

15:30-16:00               

Galenical Considerations and Application Systems for Paediatric and Geriatric Patients
Cedric Gysel, Sustainable Innovations, Johnson & Johnson, Neuhausen

16:00-16:30               

Nutrigenomics : Interventions for the Aging Population
Jorg Hager, Nestlé Institute of Health Sciences, Lausanne

SESSION V: Legal Considerations for Vulnerable Populations

16:30-17:00               

Legal Considerations of Clinical Testing in Vulnerable Populations
Brigitte Tag, Faculty of Law, University of Zurich

17:00  Résumé

Apéro